Joris Wilms

Insider Reports History

Entity
Individual
Location
C/O Y Mabs Therapeutics, Inc., 230 Park Avenue, 33 Rd Floor, New York, NY
Signature
/s/ John LaRocca, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joris Wilms:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Y-mAbs Therapeutics, Inc. SVP & CHIEF OPERATING OFFICER Common Stock 30.6K $450K $14.69 Aug 26, 2024 Direct
Y-mAbs Therapeutics, Inc. SVP & CHIEF OPERATING OFFICER Employee Stock Option (right to buy) 35.7K Jan 18, 2024 Direct

Insider Reports Filed by Joris Wilms

Symbol Company Period Transactions Value $ Form Type Date Filed Role
YMAB Y-mAbs Therapeutics, Inc. Aug 26, 2024 1 -$73.5K 4 Aug 27, 2024 SVP & CHIEF OPERATING OFFICER
YMAB Y-mAbs Therapeutics, Inc. Jan 18, 2024 2 $0 4 Jan 22, 2024 SVP & CHIEF OPERATING OFFICER
YMAB Y-mAbs Therapeutics, Inc. Jan 26, 2023 1 $0 4 Jan 30, 2023 SVP & CHIEF OPERATING OFFICER
YMAB Y-mAbs Therapeutics, Inc. Jan 17, 2023 2 $0 4 Jan 19, 2023 SVP & CHIEF OPERATING OFFICER
YMAB Y-mAbs Therapeutics, Inc. Apr 26, 2022 1 $0 4 Apr 28, 2022 SVP & COO
YMAB Y-mAbs Therapeutics, Inc. Dec 14, 2021 1 $0 4 Dec 16, 2021 SVP & COO